Search results for: 'detection of pollution carbonaceous particles biological sample'
- Did you mean
- detection of pollution carbonaceous particles biologics sale
- detection of polluting carbonaceous particles biological sale
- Related search terms
- Sample Preparation Market by Product
- biological market in agriculture
- biologicals market in agriculture
- detection of polluting carbonaceous particip biologics sales
- detection of polluting carbonaceous particip biologics sale
-
27 Jun 2006  |  North America  |  Market Research
U.S. Medical Imaging Computer-Aided Detection (CAD) Markets
This research study analyzes the U.S. Computer Aided Detection (CAD) market from 2002 to 2012 with a base year of 2005. The main chapters of the report include an executive summary, overview of the CAD equipment market and in depth analysis of the CAD market by application type.
$6,950.00
Special Price $5,212.50 save 25 %
-
07 Sep 2015  |  North America  |  Market Research
US Nucleic Acid Purification and Isolation Markets
Critical Sample Preparation Step Benefits from Downstream Applications
The total market, as defined by this study, includes nucleic acid purification and isolation reagents (including kits and homebrew reagents) and nucleic acid purification and isolation instruments in the United States. The study period runs from 2011 to 2021, with 2014 as the base year and 2015–2021 as the forecast period. This research service off...
$4,950.00
Special Price $3,712.50 save 25 %
-
12 Apr 2018  |  Europe  |  Market Research
Global Biologics Contract Development & Manufacturing Organization (CDMO) Market—Companies-to-Action
Establishment of Need-based Business Models with Advancements in Manufacturing Techniques is Driving Market Growth
The study on the "Global Biologics Contract Development & Manufacturing Organizations (CDMO) Market: Companies-to-Action" presents an overview of the global biologics development and manufacturing landscape with an emphasis on the seven leading CDMOs in the market. The study highlights the shifting focus and investments of bio-pharma companies towa...
$3,000.00
Special Price $2,250.00 save 25 %
-
24 Jul 2020  |  North America  |  Market Research
Curative Oncology and Rare Disease Therapies Transforming the Global Biologics Market, 2020–2024
Strategic Collaborations with Specialty Bio-CDMOs will Continue to Drive Growth Opportunities in Antibody-drug Conjugates and Gene Therapies
With this research service, Frost & Sullivans Transformational Health team provides critical insights into the global biologics industry highlighting the growth opportunities, market revenue segmentation, and technology trends influencing its growth. The global biologics market covered in this study includes 4 major segments – antibody therapies, r...
$4,950.00
Special Price $3,712.50 save 25 %
-
15 Feb 2022  |  North America  |  Market Research
Global Biologics Contract Development and Manufacturing Organization Profiles and Growth Opportunities
The Contract Research, Development, and Manufacturing Organization Business Model to Drive Future Growth Potential
Frost & Sullivan provides comprehensive insights into the global biologics contract development and manufacturing organization (bio-CDMO) market, including emerging trends, growth opportunities, and profiles of leading bio-CDMOs and their business model evolution. The growth of next-generation biologics and personalized therapies and the emergence ...
$2,450.00
Special Price $1,837.50 save 25 %
-
02 May 2011  |  North America  |  Market Research
U.S. Rheumatoid Arthritis Market: Assessment of Biologics and New Treatments
This research service covers the U.S. rheumatoid arthritis (RA) market from 2007 to 2017, with 2010 as the base year. Included in this research service are products currently in the market, products in development, and patient forecasts. Market challenges, drivers, and restraints are identified and assessed. Strategic recommendations are presented ...
$4,950.00
Special Price $3,712.50 save 25 %
-
17 Sep 2018  |  Europe  |  Market Research
Mammography Computer Aided Detection (Mammo CAD) Market in Western Europe, Forecast to 2022
With Low Penetration, Business Models are Capitalizing on Disruptive Innovations
This insight presents an analysis of the mammography CAD (computer aided detection) market in Western Europe. It provides an in-depth analysis of the current trends, market size, revenue forecast, market penetration and market attractiveness, both in the two dimensional (2D) and three dimensional (3D) CAD markets. X-ray Mammography is the gold sta...
$3,000.00
Special Price $2,250.00 save 25 %
-
22 Aug 2025  |  Global  |  Technology Research
Recent Advances in Biomarker Technologies, Radiopharmaceuticals and Biologics
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights into recent technological developments for molecular marker detection, drug delivery, cancer immunotherapies and radiopharmaceuticals. The TOE also comprises analysis of innovations across cell and gene therapy, antibody and gene editing platfo...
$950.00 -
17 Jun 2021  |  North America  |  Market Research
Global Biologics Contract Development and Manufacturing Organizations Growth Opportunities
Asset Co-Development with Clinical-stage Biopharmaceutical Companies and Disruptive Technologies Present Future Growth Potential
This study presents Frost & Sullivans overall market and segment-wise revenue forecasts of the global biologics contract development and manufacturing organizations (bio-CDMO) market. It also highlights key growth opportunities for bio-CDMO market participants based on the main evolution in their business models and strategic approaches, as well as...
$4,950.00
Special Price $3,712.50 save 25 %
-
08 Jun 2022  |  North America  |  Market Research
Growth Opportunities in Sterile Injectable Outsourcing
Biologics Drive the Future Growth Potential of Sterile Injectable Outsourcing
Injectables constitute one of the fastest growing segments in the pharmaceuticals space. Many drugs, including biologics, are going off patent in next 3 or 4 years, which will lead to an increase in the demand for generics and biosimilar injectables. The increase in onshoring and nearshoring of biopharmaceutical products for COVID-19 and next-gen...
$2,450.00
Special Price $1,837.50 save 25 %